Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.29 USD | +1.44% | +21.08% | 0.00% |
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Revenues | 211M | 320M |
Total Revenues | 211M | 320M |
Cost of Goods Sold, Total | 46.18M | 43.99M |
Gross Profit | 165M | 276M |
Selling General & Admin Expenses, Total | 159M | 166M |
R&D Expenses | 42.56M | 49.83M |
Depreciation & Amortization - (IS) | 3.05M | 3.66M |
Other Operating Expenses, Total | 205M | 220M |
Operating Income | -40.31M | 56.17M |
Interest Expense, Total | -5.31M | -6.88M |
Net Interest Expenses | -5.31M | -6.88M |
Other Non Operating Income (Expenses) | -4.44M | -5.06M |
EBT, Excl. Unusual Items | -50.07M | 44.22M |
Gain (Loss) On Sale Of Investments | -4.53M | - |
Asset Writedown | - | -169K |
EBT, Incl. Unusual Items | -54.6M | 44.05M |
Income Tax Expense | 262K | 5.93M |
Earnings From Continuing Operations | -54.86M | 38.12M |
Net Income to Company | -54.86M | 38.12M |
Net Income - (IS) | -54.86M | 38.12M |
Net Income to Common Incl Extra Items | -54.86M | 38.12M |
Net Income to Common Excl. Extra Items | -54.86M | 38.12M |
Per Share Items | ||
Net EPS - Basic | -6.33 | 4.26 |
Basic EPS - Continuing Operations | -6.33 | 4.26 |
Basic Weighted Average Shares Outstanding | 8.67M | 8.95M |
Net EPS - Diluted | -6.33 | 1.42 |
Diluted EPS - Continuing Operations | -6.33 | 1.42 |
Diluted Weighted Average Shares Outstanding | 8.67M | 26.92M |
Normalized Basic EPS | -3.61 | 3.09 |
Normalized Diluted EPS | -3.61 | 1.03 |
Supplemental Items | ||
EBITDA | -38.09M | 58.13M |
EBITA | -40.31M | 56.17M |
EBIT | -40.31M | 56.17M |
EBITDAR | -35.5M | 60.51M |
Effective Tax Rate - (Ratio) | -0.48 | 13.47 |
Current Domestic Taxes | 262K | 5.93M |
Total Current Taxes | 262K | 5.93M |
Normalized Net Income | -31.29M | 27.64M |
Interest on Long-Term Debt | 6.2M | 8.8M |
Supplemental Operating Expense Items | ||
Advertising Expense | 29.6M | 24.7M |
Selling and Marketing Expenses | 110M | 115M |
General and Administrative Expenses | 46.57M | 51.63M |
Research And Development Expense From Footnotes | 45.86M | 54.7M |
Net Rental Expense, Total | 2.59M | 2.38M |
Imputed Operating Lease Interest Expense | - | 1.96M |
Imputed Operating Lease Depreciation | - | 420K |
Stock-Based Comp., COGS (Total) | 854K | 659K |
Stock-Based Comp., R&D Exp. (Total) | 1.84M | 2.07M |
Stock-Based Comp., S&M Exp. (Total) | 1.84M | 15.42M |
Stock-Based Comp., G&A Exp. (Total) | 1.98M | 2.02M |
Total Stock-Based Compensation | 6.5M | 20.17M |
- Stock Market
- Equities
- IBTA Stock
- Financials Ibotta, Inc.
- Income Statement
MarketScreener is also available in this country: United States.
Switch edition